TY  - JOUR
AU  - Cairat, Manon
AU  - Fournier, Agnès
AU  - Murphy, Neil
AU  - Biessy, Carine
AU  - Scalbert, Augustin
AU  - Rinaldi, Sabina
AU  - Tjønneland, Anne
AU  - Olsen, Anja
AU  - Overvad, Kim
AU  - Arveux, Patrick
AU  - Boutron-Ruault, Marie-Christine
AU  - Cadeau, Claire
AU  - Turzanski-Fortner, Renée
AU  - Kaaks, Rudolf
AU  - Boeing, Heiner
AU  - Aleksandrova, Krasimira
AU  - Peeters, Petra H M
AU  - Van Gils, Carla H
AU  - Wareham, Nicholas J
AU  - Khaw, Kay-Tee
AU  - Aune, Dagfinn
AU  - Riboli, Elio
AU  - Gunter, Marc J
AU  - Dossus, Laure
TI  - Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study.
JO  - International journal of cancer
VL  - 143
IS  - 7
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2018-01419
SP  - 1688 - 1695
PY  - 2018
AB  - Experimental studies have shown a protective effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on breast cancer development. However, results from epidemiological cohort studies are less consistent. Our objective was to assess the association between NSAID use and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Self-reported information on NSAID use at baseline has been collected in five EPIC countries. Multivariable Cox regression models were used to estimate hazard ratios for the association of NSAID use with breast cancer incidence with adjustment for potential confounders. We also assessed effect modification by breast cancer risk factors and examined the associations within specific breast cancer subtypes. Among the 140,981 women included in the analysis, 7
LB  - PUB:(DE-HGF)16
C6  - pmid:29707771
DO  - DOI:10.1002/ijc.31570
UR  - https://inrepo02.dkfz.de/record/136991
ER  -